| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373293A1 Steap-related protein |
| 01/02/2004 | EP1372786A2 Cytoprotection by phosphotyrosine |
| 01/02/2004 | EP1372751A1 Cartilaginous neo-tissue capable of being grafted |
| 01/02/2004 | EP1372750A1 Method for preparing a cartilaginous neo-tissue |
| 01/02/2004 | EP1372736A2 Anti-neovasculature preparations for cancer |
| 01/02/2004 | EP1372723A1 Semi-allogenic anti-tumour vaccine with hla haplo-identical antigen-presenting cells |
| 01/02/2004 | EP1372718A2 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 01/02/2004 | EP1372716A2 Blood cell production via activation of the hemoglobin scavenger receptor (cd163) |
| 01/02/2004 | EP1372691A2 Mucin peptide with immunoenhancing properties |
| 01/02/2004 | EP1372690A2 93870, a human g-protein coupled receptor and uses therefor |
| 01/02/2004 | EP1372688A2 Somatostatin antagonists |
| 01/02/2004 | EP1372670A1 Caloporoside derivatives, methods for the production thereof and their use |
| 01/02/2004 | EP1372418A2 Non-oligomerizing tandem fluorescent proteins |
| 01/02/2004 | EP1372398A2 Rapid preparation of stem cell matrices for use in tissue and organ treatement and repair |
| 01/02/2004 | EP0746343B1 Bioartificial kidney devices coated with cells suitable for use in vivo or ex vivo |
| 01/02/2004 | EP0719343B1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 01/01/2004 | US20040003431 Genes coding for flavone synthases |
| 01/01/2004 | US20040003427 Novel basal endosperm transfer cell layer (BELT) specific genes |
| 01/01/2004 | US20040003425 Nav2 channel gene-deficient non-human animals |
| 01/01/2004 | US20040003424 Transgenic cardiomyocytes with controlled proliferation and differentiation |
| 01/01/2004 | US20040003422 An expression cassette containing the proopiomelanocortin (POMC) enhancer, and a nucleic acid sequence encoding POMC contains at least one exon, wherein a polylinker having an unique site for restriction enzyme is inserted into the exon; gene regulates weight and fat mass |
| 01/01/2004 | US20040003419 Novel taste receptors in Drosophila |
| 01/01/2004 | US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| 01/01/2004 | US20040003417 Animals transgenic for a tetracycline-regulated transcriptional inhibitor |
| 01/01/2004 | US20040002740 System and method for forming a non-ablative cardiac conduction block |
| 01/01/2004 | US20040002585 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 01/01/2004 | US20040002473 Pain modulation; incotinence therapy; central nervous system disorders |
| 01/01/2004 | US20040002468 Methods of treating diabetes and other blood sugar disorders |
| 01/01/2004 | US20040002467 Antisense modulation of ADAM12 expression |
| 01/01/2004 | US20040002460 Spheron components useful in determining compounds capable of treating symptoms of Alzheimer's disease, and treatments and animal models produced therefrom |
| 01/01/2004 | US20040002459 Nucleic acids encoding kringle 1-5 region fragments of plasminogen |
| 01/01/2004 | US20040002458 Pharmaceutical compositions and methods using natriuretic peptides |
| 01/01/2004 | US20040002449 METH1 and METH2 polynucleotides and polypeptides |
| 01/01/2004 | US20040002447 Induction of insulin expression |
| 01/01/2004 | US20040002439 Human voltage gated sodium channel beta1A subunit and methods of use |
| 01/01/2004 | US20040002159 Methods for the production of chimeric adeno-associated virus (AAV) vectors, compositions of chimeric AAV vectors, and methods of use thereof |
| 01/01/2004 | US20040002152 Oligonucleotides specifically hybridizable with nucleic acids encoding P2X4; P2X4 is a subfamily of the purinoreceptors that are ligand-gated ion channels that respond to the endogenous occurring neurotransmitter Adenosine Triphosphate |
| 01/01/2004 | US20040002151 Antisense modulation of selenophosphate synthetase 2 expression |
| 01/01/2004 | US20040002150 Antisense modulation of hypothetical protein LOC51249 expression |
| 01/01/2004 | US20040002139 Methods for making recombinant proteins using apoptosis inhibitors |
| 01/01/2004 | US20040002135 Adapted NS0 cell lines with the ability to grow under glutamine-free conditions |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002123 Detection of transmembrane potentials by optical methods |
| 01/01/2004 | US20040002122 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 01/01/2004 | US20040002114 Nucleic acids encoding a G-protein coupled receptor involved in islet cell signaling |
| 01/01/2004 | US20040002109 Process for identifying modulators of G-protein-coupled receptors |
| 01/01/2004 | US20040002103 Synthetic ligation reassembly in directed evolution |
| 01/01/2004 | US20040002092 Hybrid and single chain meganucleases and use thereof |
| 01/01/2004 | US20040002088 Identification and isolation of novel DNA and to the recombinant production of polypeptides having sequence similarity to Glial Cell line-derived Neurotrophic Factor Receptor (GDNFR) |
| 01/01/2004 | US20040002066 36 human secreted proteins |
| 01/01/2004 | US20040002062 Retrovirus-based genomic screening |
| 01/01/2004 | US20040002061 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells |
| 01/01/2004 | US20040002060 For efficient targeting of adenoviral vectors; can be combined with other modifications, such as fiber knob and/or penton modifications, to produce fully ablated (detargeted) adenoviral vectors |
| 01/01/2004 | US20040002055 Support with collage base for tissue engineering and manufacture of biomaterials |
| 01/01/2004 | US20040001867 Vectors for molecule delivery to CD11b expressing cells |
| 01/01/2004 | US20040001860 Dietary supplements for enhancing the immune system |
| 01/01/2004 | US20040001844 Lewis Y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 01/01/2004 | US20040001832 Childhood obesity; antidiabetic agents; culture product; hybrid nucleic acid |
| 01/01/2004 | US20040001829 Methods for selectively stimulating proliferation of T cells |
| 01/01/2004 | US20040001810 Administering dosage of nucleic acids; cardiovascular disorders |
| 01/01/2004 | US20040001808 Compositions and methods for the use of Bcl-2 transfected neurons |
| 01/01/2004 | US20040001807 Genetic engineering bone marrow cells; therapy for cardiovascular disorders |
| 01/01/2004 | US20040001806 Culture product containing interleukins and colony stimulanting factor; antitumor agents |
| 01/01/2004 | US20040001805 Prevention infections; gene therapy; insertion of genome; genetic engineered vaccine |
| 12/31/2003 | WO2004001381A2 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 12/31/2003 | WO2004001367A2 Test system for identifying cancerous diseases |
| 12/31/2003 | WO2004001061A2 Antisense modulation of heme oxygenase 1 expression |
| 12/31/2003 | WO2004001047A1 Novel promoter |
| 12/31/2003 | WO2004001032A2 Stable adenoviral vectors and methods for propagation thereof |
| 12/31/2003 | WO2004001025A1 Use of thrombopoietin for cultivating hepatocytes |
| 12/31/2003 | WO2004001024A2 Genetically engineered keratinocytes expressing at least one growth factor and/or activated egf receptor, skin equivalent comprising said keratinocytes and toxicity assay using said keratinocytes |
| 12/31/2003 | WO2004001023A2 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
| 12/31/2003 | WO2004001014A2 Osteopontin, oligodendrocytes and myelination |
| 12/31/2003 | WO2004001003A2 Plastid division and related genes and proteins, and methods of use |
| 12/31/2003 | WO2004001001A2 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 12/31/2003 | WO2004000993A2 Oxytocin as cardiomyogenesis inducer and uses thereof |
| 12/31/2003 | WO2004000871A2 Thioesterase-related nucleic acid sequences and methods |
| 12/31/2003 | WO2004000722A1 Patterning nanofeatures over large areas |
| 12/31/2003 | WO2004000444A1 Tangential flow filtration devices and methods for leukocyte enrichment |
| 12/31/2003 | WO2004000415A2 Tissue reconstruction and regeneration |
| 12/31/2003 | WO2004000369A2 Method of magnetically manipulating a cell with magnetisable particles |
| 12/31/2003 | WO2004000367A1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension |
| 12/31/2003 | WO2004000217A2 Vaccines for suppressing ige-mediated allergic disease and methods for using the same |
| 12/31/2003 | WO2004000213A2 Method for growing human organs, treating diseases, and increasing longevity |
| 12/31/2003 | WO2004000102A2 Method for predicting response to epidermal growth factor receptor-directed therapy |
| 12/31/2003 | WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia |
| 12/31/2003 | WO2003064471A3 Gene for peripheral arterial occlusive disease |
| 12/31/2003 | WO2003060077A3 Endothelial stem cells, populations, methods of isolation and use thereof |
| 12/31/2003 | WO2003057719A3 Methods of modulating localization and physiological function of ip3 receptors |
| 12/31/2003 | WO2003057708A3 Fusion proteins |
| 12/31/2003 | WO2003056022A3 Method for producing a transgenic organism using a lentiviral expression vector such as eiav |
| 12/31/2003 | WO2003055916A3 Adiponectin fragments and conjugates |
| 12/31/2003 | WO2003055912A3 Secreted proteins |
| 12/31/2003 | WO2003051283A3 Engineered bone marrow |
| 12/31/2003 | WO2003048310A3 Thermus oshimai nucleic acid polymerases |
| 12/31/2003 | WO2003048208A3 Expression control using variable intergenic sequences |
| 12/31/2003 | WO2003047606A3 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors |
| 12/31/2003 | WO2003046129A3 Compositions for the derivation of germ cells from stem cells and methods of use thereof |
| 12/31/2003 | WO2003039344A3 Methods and compositions for correction of cardiac conduction disturbances |